Interaction of cytotoxic T lymphocytes and guinea pig ventricular myocytes - Pharmacological modulation by blocking K+ currents in cytotoxic T lymphocytes

Infiltrating cytotoxic T lymphocytes (CTLs) are important immune effecters that damage the myocardium during heart transplant rejection as well as in cardiomyopathy and Chagas' heart disease. We have previously shown that in an in vitro model of murine-derived peritoneal exudate CTL (PEL)-guinea pig ventricular myocyte interaction, PEL induced in conjugated myocytes reduction of resting membrane potential and action potential (AP) amplitude, shortening of AP duration, delayed afterdepolarizations (DADs), and myocyte contracture and destruction. Since these findings indicated that cytotoxicity was largely caused by [Ca2+](i) overload, in the present study we tested the hypothesis that blocking the L-type Ca2+ current (I-Ca,I-L) in the myocyte will eliminate the trigger for Ca2+ release from intracellular stores and will reduce [Ca2+](i) overload and subsequent myocyte deterioration. CoCl2 (3 mmol/L) prevented PEL-induced AP changes, induction of DADs, and myocyte destruction. Since verapamil (2 mu mol/L) was ineffective, indicating that the CoCl2 protection was not due to block of I-Ca,I-L we tested whether the different action of these Ca2+ channel blockers was due to their differential effect on the PEL's K+ current (I-K), previously shown to participate in lymphocyte activation and cytotoxicity. In agreement with their protective efficacy, CoCl2, but not verapamil blocked I-K in PELs, suggesting that this is the mechanism for the protection provided by CoCl2. To support this notion, we tested the effect of the scorpion-derived peptide margatoxin (10 nmol/L), a specific K+ channel blocker in lymphocytes, on PEL-myocyte interaction and on PEL's I-K; margatoxin prevented PEL-induced cytotoxicity and also blocked I-K in PEL. Based on these findings, an alternative modality for attenuating CTL-induced lymphocytotoxicity is proposed.